- Life Science Cares Launches in Switzerland
- Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting
- Molecular Partners Publishes Invitation to Annual General Meeting 2024
- Molecular Partners Reports Corporate Highlights From Q4 2023 and Key Financials for Full Year 2023
- Molecular Partners Announces Dismissal of Class Action Lawsuit
- Molecular Partners To Hold Conference Call to Discuss Fourth Quarter and Full Year 2023 Results and Announces Upcoming Investor Presentations
- Molecular Partners Presents Positive Initial Data from First Four Dosing Cohorts of Ongoing Phase 1/2a Trial of MP0533 for Patients with Relapsed/Refractory AML and AML/MDS at ASH Annual Meeting
More ▼
Key statistics
As of last trade Molecular Partners AG (MOLN:SWX) traded at 3.20, 5.26% above its 52-week low of 3.04, set on Oct 27, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.27 |
---|---|
High | 3.36 |
Low | 3.20 |
Bid | 3.19 |
Offer | 3.36 |
Previous close | 3.20 |
Average volume | 8.33k |
---|---|
Shares outstanding | 36.37m |
Free float | 33.00m |
P/E (TTM) | -- |
Market cap | 116.38m CHF |
EPS (TTM) | -1.89 CHF |
Data delayed at least 15 minutes, as of Apr 25 2024 16:31 BST.
More ▼